Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Cancer-related fatigue, inflammation and thyrotropin-releasing hormone.

Kamath J.

Curr Aging Sci. 2012 Dec;5(3):195-202. Review.

PMID:
23387883
2.

Thyrotropin-releasing hormone as a treatment for cancer-related fatigue: a randomized controlled study.

Kamath J, Feinn R, Winokur A.

Support Care Cancer. 2012 Aug;20(8):1745-53. doi: 10.1007/s00520-011-1268-8. Epub 2011 Sep 27.

PMID:
21947558
3.

The thyrotropin-releasing hormone (TRH)-immune system homeostatic hypothesis.

Kamath J, Yarbrough GG, Prange AJ Jr, Winokur A.

Pharmacol Ther. 2009 Jan;121(1):20-8. doi: 10.1016/j.pharmthera.2008.09.004. Epub 2008 Oct 21. Review.

PMID:
19000920
4.

Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.

Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR.

J Clin Oncol. 2008 Feb 20;26(6):971-82. doi: 10.1200/JCO.2007.10.7805. Review.

5.

Thyrotropin-releasing hormone can relieve cancer-related fatigue: hypothesis and preliminary observations.

Kamath J, Yarbrough GG, Prange AJ Jr, Winokur A.

J Int Med Res. 2009 Jul-Aug;37(4):1152-7.

PMID:
19761698
6.

Fatigue in Patients With Advanced Terminal Cancer Correlates With Inflammation, Poor Quality of Life and Sleep, and Anxiety/Depression.

Rodrigues AR, Trufelli DC, Fonseca F, de Paula LC, Giglio AD.

Am J Hosp Palliat Care. 2016 Dec;33(10):942-947. Epub 2015 Aug 30.

PMID:
26324072
7.

Effects of thyrotropin-releasing hormone on the sleep EEG and nocturnal hormone secretion in male volunteers.

Hemmeter U, Rothe B, Guldner J, Holsboer F, Steiger A.

Neuropsychobiology. 1998;38(1):25-31.

PMID:
9701719
8.

Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in hemodialysis patients.

Chen HY, Cheng IC, Pan YJ, Chiu YL, Hsu SP, Pai MF, Yang JY, Peng YS, Tsai TJ, Wu KD.

Kidney Int. 2011 Aug;80(4):415-22. doi: 10.1038/ki.2011.151. Epub 2011 Jun 8.

9.

Cancer-related fatigue: links with inflammation in cancer patients and survivors.

Bower JE.

Brain Behav Immun. 2007 Oct;21(7):863-71. Epub 2007 May 31. Review.

10.

Inflammation, sleep disturbances, and depressed mood among community-dwelling older men.

Smagula SF, Ancoli-Israel S, Barrett-Connor E, Lane NE, Redline S, Stone KL, Cauley JA; Osteoporotic Fractures in Men (MrOS) Research Group.

J Psychosom Res. 2014 May;76(5):368-73. doi: 10.1016/j.jpsychores.2014.02.005. Epub 2014 Feb 22.

11.

Sleep disturbance, inflammation and depression risk in cancer survivors.

Irwin MR, Olmstead RE, Ganz PA, Haque R.

Brain Behav Immun. 2013 Mar;30 Suppl:S58-67. doi: 10.1016/j.bbi.2012.05.002. Epub 2012 May 24. Review.

12.

Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety.

Gutiérrez-Mariscal M, de Gortari P, López-Rubalcava C, Martínez A, Joseph-Bravo P.

Psychoneuroendocrinology. 2008 Feb;33(2):198-213.

PMID:
18079066
13.

Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?

Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW.

J Clin Oncol. 2011 Sep 10;29(26):3517-22. doi: 10.1200/JCO.2011.36.1154. Epub 2011 Aug 8.

14.

Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression.

Szuba MP, Amsterdam JD, Fernando AT 3rd, Gary KA, Whybrow PC, Winokur A.

J Clin Psychopharmacol. 2005 Aug;25(4):325-30. Erratum in: J Clin Psychopharmacol. 2005 Dec;25(6):538. Fernando, Antonio T 3rd [added]; Gary, Keith A [added]; Whybrow, Peter C [added]; Winokur, Andrew [added].

PMID:
16012274
15.
16.

Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.

Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S.

Brain Behav Immun. 2012 Jul;26(5):706-13. doi: 10.1016/j.bbi.2012.02.001. Epub 2012 Mar 2.

17.

Mechanisms of cancer-related fatigue.

Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR.

Oncologist. 2007;12 Suppl 1:22-34. Review.

18.

Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs.

Monga V, Meena CL, Kaur N, Jain R.

Curr Med Chem. 2008;15(26):2718-33. Review.

PMID:
18991632
19.

Lack of correlation between cerebrospinal fluid thyrotropin-releasing hormone (TRH) and TRH-stimulated thyroid-stimulating hormone in patients with depression.

Frye MA, Dunn RT, Gary KA, Kimbrell TA, Callahan AM, Luckenbaugh DA, Corá-Locatelli G, Vanderham E, Winokur A, Post RM.

Biol Psychiatry. 1999 Apr 15;45(8):1049-52.

PMID:
10386189
20.

Assessment of sleep disturbance in lung cancer patients: relationship between sleep disturbance and pain, fatigue, quality of life, and psychological distress.

Nishiura M, Tamura A, Nagai H, Matsushima E.

Palliat Support Care. 2015 Jun;13(3):575-81. doi: 10.1017/S1478951513001119. Epub 2014 Feb 13.

PMID:
24524428

Supplemental Content

Support Center